SEC Form 4 · Updated Daily
ABUS
— ARBUTUS BIOPHARMA CORPORATION OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| McElhaugh Michael J. | Officer | 1,658,003 | 2025-02-14 | A |
| Sofia Michael J. | Officer | 1,485,121 | 2024-02-02 | S |
| HASTINGS DAVID C | Officer | 249,824 | 2025-02-14 | A |
| Sims Karen | Officer | 155,494 | 2025-02-14 | A |
| Naftzger J. Christopher | Officer | 140,544 | 2025-02-14 | A |
| Nguyen Tuan | Officer | 73,500 | 2026-02-02 | A |
| MANCHESTER KEITH S | Director | 46,069 | 2024-08-14 | S |
| Androski Lindsay | Director · Officer | 28,000 | 2026-02-02 | A |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-06-08 | Beardsley Robert A | Grant / award (derivative) | 78,800 | $0.00 | 78,800 |
| 2026-06-08 | Sawhney Roger | Grant / award (derivative) | 78,800 | $0.00 | 78,800 |
| 2026-02-02 | Androski Lindsay | Grant / award (derivative) | 71,700 | $0.00 | 71,700 |
| 2026-02-02 | Androski Lindsay | Grant / award | 28,000 | $0.00 | 28,000 |
| 2026-02-02 | Nguyen Tuan | Grant / award (derivative) | 188,400 | $0.00 | 188,400 |
| 2026-02-02 | Nguyen Tuan | Grant / award | 73,500 | $0.00 | 73,500 |
| 2025-08-04 | Sawhney Roger | Grant / award (derivative) | 157,600 | $0.00 | 157,600 |
| 2025-03-31 | Nguyen Tuan | Grant / award (derivative) | 750,000 | $0.00 | 750,000 |
| 2025-03-31 | Nguyen Tuan | Grant / award (derivative) | 750,000 | $0.00 | 750,000 |
| 2025-03-18 | Androski Lindsay | Grant / award (derivative) | 310,422 | $0.00 | 310,422 |
| 2025-03-18 | Beardsley Robert A | Grant / award (derivative) | 157,600 | $0.00 | 157,600 |
| 2025-03-18 | Hasija Anuj | Grant / award (derivative) | 157,600 | $0.00 | 157,600 |
| 2025-02-14 | Sims Karen | Grant / award (derivative) | 200,300 | $0.00 | 200,300 |
| 2025-02-14 | Sims Karen | Grant / award | 49,300 | $0.00 | 155,494 |
| 2025-02-14 | HASTINGS DAVID C | Grant / award (derivative) | 365,800 | $0.00 | 365,800 |
| 2025-02-14 | HASTINGS DAVID C | Grant / award | 90,100 | $0.00 | 249,824 |
| 2025-02-14 | McElhaugh Michael J. | Grant / award (derivative) | 718,800 | $0.00 | 718,800 |
| 2025-02-14 | McElhaugh Michael J. | Grant / award | 177,000 | $0.00 | 1,658,003 |
| 2025-02-14 | Naftzger J. Christopher | Grant / award (derivative) | 220,300 | $0.00 | 220,300 |
| 2025-02-14 | Naftzger J. Christopher | Grant / award | 54,300 | $0.00 | 140,544 |
| 2025-02-04 | Naftzger J. Christopher | Open-market sale | 11,333 | $3.28 | 86,244 |
| 2025-02-04 | McElhaugh Michael J. | Open-market sale | 23,790 | $3.28 | 1,481,003 |
| 2025-02-04 | Sims Karen | Open-market sale | 19,348 | $3.28 | 106,194 |
| 2025-02-04 | HASTINGS DAVID C | Open-market sale | 22,183 | $3.28 | 159,724 |
| 2024-08-14 | MANCHESTER KEITH S | Option exercise (derivative) | 54,915 | $0.00 | 0 |
| 2024-08-14 | MANCHESTER KEITH S | Open-market sale | 8,846 | $3.69 | 46,069 |
| 2024-08-14 | MANCHESTER KEITH S | Option exercise | 54,915 | $0.56 | 54,915 |
| 2024-05-23 | Torti Frank | Grant / award (derivative) | 67,000 | $0.00 | 67,000 |
| 2024-05-23 | Rewolinski Melissa | Grant / award (derivative) | 67,000 | $0.00 | 67,000 |
| 2024-05-23 | Meyers James R | Grant / award (derivative) | 67,000 | $0.00 | 67,000 |
| 2024-05-23 | HENRIQUES RICHARD C JR | Grant / award (derivative) | 67,000 | $0.00 | 67,000 |
| 2024-05-23 | MANCHESTER KEITH S | Grant / award (derivative) | 67,000 | $0.00 | 67,000 |
| 2024-05-23 | BURGESS DANIEL D | Grant / award (derivative) | 67,000 | $0.00 | 67,000 |
| 2024-02-02 | McElhaugh Michael J. | Open-market sale | 10,164 | $2.31 | 1,504,793 |
| 2024-02-02 | Sofia Michael J. | Open-market sale | 9,982 | $2.31 | 1,485,121 |
| 2024-02-02 | HASTINGS DAVID C | Open-market sale | 9,593 | $2.31 | 181,907 |
| 2024-02-02 | Sims Karen | Open-market sale | 4,358 | $2.31 | 125,542 |
| 2024-02-01 | McElhaugh Michael J. | Grant / award (derivative) | 495,100 | $0.00 | 495,100 |
| 2024-02-01 | McElhaugh Michael J. | Grant / award | 123,800 | $0.00 | 1,514,957 |
| 2024-02-01 | Sofia Michael J. | Grant / award (derivative) | 437,800 | $0.00 | 437,800 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.